This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gamma, A. Articles by Vollenweider, F. X. Search for Related Content PubMed PubMed Citation Articles by Gamma, A. Articles by Vollenweider, F. X. Social Bookmarking                         What's this?

The P3 in ‘ecstasy’ polydrug users during response inhibition and execution

University Hospital of Psychiatry, Research Unit, Lenggstr. 31, 8029 Zurich, Switzerland

Daniel Brandeis

Department of Child and Adolescent Psychiatry, University of Zurich, Neumunsterallee 9, 8032 Zurich, Switzerland

Ruven Brandeis

Department of Child and Adolescent Psychiatry, University of Zurich, Neumunsterallee 9, 8032 Zurich, Switzerland

Franz X. Vollenweider

University Hospital of Psychiatry, Research Unit, Lenggstr. 31, 8029 Zurich, Switzerland, vollen{at}bli.unizh.ch

Substance abuse and associated externalizing disorders are characterized by behavioural disinhibition and low impulse control, with reduced neural inhibition postulated to be the common underlying brain mechanism. The P3 component of event-related potentials (ERPs) is a widely used neurophysiological measure thought to reflect inhibitory brain processes, but as yet has not been assessed in ecstasy users. We recorded ERPs evoked by a Continuous Performance Test (CPT) in 16 current ecstasy polydrug users and 17 controls. The CPT included conditions where a prepared motor response had to be executed (Go) or inhibited (NoGo). Both controls and ecstasy users showed normal, robust patterns of P3 anteriorization and delay in the NoGo compared to the Go condition. Ecstasy users had lower P3 amplitudes at midline electrodes and a less anterior location of NoGo P3 peaks. These effects became weaker after statistically controlling for age, educational level and lifetime cannabis use. While lower P3 amplitudes are consistent with higher levels of neural disinhibition in ecstasy polydrug users, the normal switch pattern between response execution and inhibition, and the less anterior location of the NoGo P3, do not indicate disturbed inhibitory brain mechanisms.

Key Words: ecstasy • MDMA • ERP • P3 • response inhibition • drug abuse

Journal of Psychopharmacology, Vol. 19, No. 5, 504-512 (2005)
DOI: 10.1177/0269881105056535


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?